Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-12-01
2008-12-30
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S153000
Reexamination Certificate
active
07470708
ABSTRACT:
The invention relates to compounds of the general formula (I):in which R1, R2, X,and A are as defined in claim1.These compounds can be used in the treatment of hyperglycaemia-related pathologies.
REFERENCES:
patent: 5026700 (1991-06-01), Harrison et al.
patent: 5245046 (1993-09-01), Youngdale et al.
patent: 5942540 (1999-08-01), Kozachuk
patent: 6025369 (2000-02-01), Rosenquist et al.
patent: 2003/0087926 (2003-05-01), Bloms-Funke et al.
patent: 0 398 283 (1990-11-01), None
patent: 0 433 679 (1991-06-01), None
patent: WO 03/010146 (2003-02-01), None
patent: WO 2004/007461 (2004-01-01), None
patent: WO 2004/045614 (2004-06-01), None
Harrison, Boyd L. et al: “4-′(Carboxymethyl) Oxy!-and 4-′(Carboxymethyl) Amino!-5,7-Dichloroquino Line-2-Carboxylic Acid: New Antagonists of the Strychnine-Insensitive Glycine Binding Site on the N-Methyl-D-Aspartate (NMDA) Receptor Complex” Journal of Medicinal Chemistry, 33(12), 3130-2 Coden: JMCMAR; ISSN: 0022-2623, 1990, XP001199578.
Salituro, Francesco G. et al: “3-(2-Carboxyindol-3-YL)Propionic Acid-Based Antagonists of the NMDA (N-Methyl-D-Aspartic Acid) Receptor Associated Glycine Binding Site” Journal of Medicinal Chemistry, 35(10), 1791-9 Coden: JMCMAR; ISSN: 0022-2623, 1992, XP001199577.
Database Chemabs ′Online! Chemical Abstracts Service, Columbus, Ohio, US; Kotake, Yahito et al: “Xanthurenic Acid. XVI. Inhibitory Action of 4-Hydroxy-8-Methoxyquinoline-2-Carboxylic Acid, Ethereal Sulfate of Xanthurenic Acid, and Kynurenic Acid on the Diabetogenic Property of Xanthurenic Acid” XP002294269, Retrieved From STN, Database Accession No. 1958:31214 Abstract & Journal of Biochemistry (Tokyo, Japan), 44, 787-95 Coden: Jobiao; ISSN: 0021-924X, 1957.
Carvalho et al.“Role of Endogenous Angiotensin II on Glutamatergic Actions in the Rostral Ventrolateral Medulla in Goldblatt Hypertensive Rats” Hypertension, (Oct. 2003) Journal Code: 7906255. ISSN: 1524-4563; XP008034587.
Kotake et al: “A Possible Diabetogenic Role for Tryptophan Metabolites and Effects of Xanthurenic Acid on Insulin” American Journal of Clinical Nutrition, vol. 24, No. 7, Jul. 1971, pp. 826-829, XP000867441; ISSN: 0002-9165.
Sanders et al: L-Amino Acid Inhibition of Epinephrine-Induced Hyperglycemia: Pharmacology, 6(3), 155-63 Coden: ISSN: 0031-7012, 1971, XP008034538.
Stone et al: “Endogenous Kynurenines as Targets for Drug Discovery and Development” Nature Reviews, Drug Discovery, Aug. 2002, vol. 1, No. 8, pp. 609-620, XP008034547; ISSN: 1474-1776.
Edmont et al: “Synthesis and Evaluation of Quinoline Carboxyguanidines as Antidiabetic Agents” Bioorganic & Medicinal Chemistry Letters, 1831-1834 Coden: BMCLE8, ISSN: 0960-894X, 2000, XP002294268.
Nicolaus: “Symbiotic Approach to Drug Design” Decision Makin in Drug Research, 1983, pp. 173-186, XP002197412.
Arbellot De Vacueur Annick
Correc Jean-Claude
Moinet Gerard
Merck Patent Gesellschaft mit Beschraenkter Haftung
Millen White Zelano & Branigan P.C.
Solola Taofiq A
LandOfFree
Acidic quinoline derivatives and their use for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acidic quinoline derivatives and their use for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acidic quinoline derivatives and their use for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4046610